Company: DVAX
Filing Date: 2025-05-12
Form Type: DEFA14A
Source: 0000930413-25-001695
Chunk: 8

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-05-12
Form: DEFA14A
Chunk 8
---
 reasonably predicted. While the Company is unable to address the probable significance of these
items, they could have a material impact on GAAP net income for the guidance period. A reconciliation of Adjusted EBITDA would imply a
degree of precision and certainty as to these future items that does not exist and could be confusing to investors.

For Investors:

Paul Cox
pcox@dynavax.com
510-665-0499

Or

MacKenzie Partners, Inc.
Bob Marese / John Bryan
Toll-Free: 1-800-322-2885
DVAX@mackenziepartners.com

For Media:

Dan Moore / Tali Epstein
Dynavax-CS@collectedstrategies.com